Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Q1 2021 Sanofi SA Earnings Call Transcript

Apr 28, 2021 / 12:00PM GMT
Release Date Price: $52.85 (+2.32%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi First Quarter 2021 Earnings Call. I would now like to turn the call over to Eva Schaefer-Jansen, Head of Sanofi Investor Relations. Please go ahead, Eva.

Eva Schaefer;Jansen
Sanofi - IR Officer

Good morning, and good afternoon to everyone. Thank you for joining us to review Sanofi's 2021 first quarter results followed by a Q&A session. As usual, you can find the slides to this earnings call on the Investors home page on our website at sanofi.com.

Next slide. Moving to Slide 2. I would like to remind you that information presented in this call contain forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our Document d'Enregistrement Universel for a description of these risk factors.

With that, on Slide 3, I would like to introduce our speakers for today. So we have Paul Hudson, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot